Meeting
2022 ASCO Quality Care Symposium
Estimating prevalence and financial impact of “bagging” oncology drugs: Evidence from privately-insured patients with cancer.
Authors
Ya-Chen Tina Shih
MD Anderson Cancer Center, Houston, TX
Ya-Chen Tina Shih, Ying Xu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A
Track
Cost, Value, and Policy,Health Care Access, Equity, and Disparities,Patient Experience
Sub Track
Cost and Cost-Effectiveness of Care
Citation
J Clin Oncol 40, 2022 (suppl 28; abstr 25)
DOI
10.1200/JCO.2022.40.28_suppl.025
Abstract #
25
Poster Bd #
A23
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Medicare reimbursement trends of biological reference agents and their biosimilars.
First Author: John Albaugh
Poster
2017 ASCO Annual Meeting
Clinical outcomes of patients with non-small cell lung cancer (NSCLC) receiving chemotherapy after immune checkpoint blockade.
First Author: Claud Grigg
First Author: Jeddeo Paul
Poster
2024 ASCO Annual Meeting
Cost analysis of targeted and immunotherapies in operable esophageal and non-small cell lung cancers.
First Author: Yahya Alwatari